Introduction

Anemia is a nearly universal diagnosis in preterm infants and is associated with increased morbidity and mortality worldwide.1,2,3,4,5,6,7,8 The severity of anemia often correlates with the acuity of illness, as it is caused primarily by phlebotomy essential for intensive care. Each instance of phlebotomy leads to acute blood loss, requiring adaptations that preterm infants are not mature enough to achieve.1 Low erythropoietin levels,9,10,11 low iron stores,12,13 and inadequacy of the developing bone marrow1,14 are some examples. Additionally, infants of all gestational ages experience suppression of hematopoiesis soon after birth, owing to high postnatal oxygen tension in the ambient air relative to the in utero environment.15 The overall result is that preterm infants can experience severe iatrogenic anemia without the intrinsic ability to recover.16,17,18 Red blood cell (RBC) transfusion is, therefore, a common occurrence, though it is laden with risks of its own.

Blood is a dynamic fluid predominantly composed of RBCs and plasma, with smaller proportions of white blood cells (WBCs) and platelets. Typically developing infants at term gestation are born with hematocrits nearing 60% or more, which in older children and adults would be considered polycythemia. Preterm infants often have hematocrits in the 40–50% range at birth, either due to birth prior to further RBC genesis or in some cases, due to the circumstances that led to preterm delivery.19,20,21 The primary function of RBCs is the transport of oxygen and carbon dioxide; however, carbon dioxide diffusion occurs 20× faster than oxygen and does not require as robust of a hematocrit to be expelled from the bloodstream into the lungs.22 Therefore, traditionally, the primary physiologic focus in anemic babies is hypoxemia and organ hypoxia. This study hopes to investigate further, particularly the effects of anemia on leukocytes. Leukocytes are the effector cells necessary to combat neonatal sepsis and other inflammatory diseases commonly found in preterm infants,23 and may experience alterations by phlebotomy.

In this investigation, we define the hematological changes in mouse pups due to phlebotomy-induced anemia (PIA) and the findings may help in understanding their importance in anemia-associated co-morbidities during the neonatal period.

Methods

Animals

Animal studies were approved by the Institutional Animal Care and Use Committee and complied with the National Institute of Health guide for the care and use of laboratory animals. As previously described,3,24,25 PIA was generated using C57BL/6 mice of both sexes (n = 25) by subjected to facial vein phlebotomy to remove 20 µL blood per gram body weight on days P2, 4, 6, 8, and 10, and an equivalent amount of normal saline was administered subcutaneously. In all, 20 µL of blood samples were collected using ethylenediaminetetraacetic acid-rinsed pipette tip and diluted immediately in 80 µL of CellPak (Sysmex America, Lincolnshire, IL, USA). A total of 100 µL diluted blood samples were analyzed using the XT-2000iV veterinary hematology analyzer (Sysmex, Kobe, Japan) to record a full standard hematology profile. Control animal data were collected from 25 mice from multiple litters, as each mouse could only be sampled once. In all, 20 µL was collected as previously described, at one time point between P2 and P10.

Statistical methods

Statistical analysis was performed using the GraphPad Prism software, version 9.0.0 (GraphPad Software, La Jolla, CA). In detail, the values for RBC, hemoglobin, reticulocyte, Ret-Hb, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), red cell distribution width (RDW), WBC, monocyte, neutrophil, and lymphocytes were statistically analyzed using a two-way analysis of variance with Šídák’s multiple-comparisons test. The values of immature reticulocyte fraction (IRF), Ret-LFR, Ret-MFR, and Ret-HFR were analyzed using Student’s t test with Mann–Whitney test. Differences were considered significant at *p < 0.05, *p < 0.01, ***p < 0.001, and ns = not significant. For comparative analysis, age-wise PIA group experiments were compared to their same-age control groups.

Results

PIA is associated with loss of RBCs and their hemoglobin

Serial timed phlebotomy (20% vol/body weight in grams) in neonatal mice resulted in a significant reduction in RBC count (×106/μL) as well as their hemoglobin (g/dL). In control mice (n = 25), the number of RBCs increased over the neonatal period from P2 (3.624 ± 0.12 SD) to P10 (4.728 ± 0.08 SD) and PIA mouse pups (n = 25) showed reduction of RBCs from P6 onwards (2.838 ± 0.05 SD), with an approximately 50% reduction at P10 (2.387 ± 0.07 SD; p < 0.001) (Fig. 1a). Corroborating this loss of RBCs, the hemoglobin content declined from P6 (6.260 ± 0.10 SD) onwards, reaching 50% reduction at P10 (3.540 ± 0.08 SD; p < 0.001) (Fig. 1b).

Fig. 1: Phlebotomy-induced anemia is associated with loss of RBCs and their hemoglobin.
figure 1

Line diagram (means ± SE) shows the (a) count of RBCs [×106/μL] and (b) serial measurement of hemoglobin [g/dL] in control vs. phlebotomy-induced anemic mice (hematocrit 20–24%); data represent 25 mice/each group; Šídák’s multiple comparisons test; ***P < 0.001 vs. respective age control.

Neonatal anemia in mice alters reticulocyte properties

PIA pups showed significant elevation of reticulocyte percentage from P6 (3.441 ± 0.10 SD vs. control; p < 0.001) to P10 (3.599 ± 0.10 SD vs. control; p < 0.001; n = 25 per each group) (Fig. 2a). But the hemoglobin in reticulocytes (pg) gradually dropped over the period of mouse pup development (P2; 27.67 ± 0.30 to P10; 15.94 ± 0.09; n = 25 per each group), and phlebotomy exacerbated the loss of hemoglobin in reticulocytes (pg) from P4 (20.98 ± 0.20 SD) to P10 (13.32 ± 0.15 SD) (Fig. 2b). The increased reticulocyte count in P10 anemic mice suggested a likely higher IRF (%), which was confirmed (69.03 ± 0.52 SD vs. control 65.05 ± 0.77 SD; p < 0.05; n = 10 per each group) (Fig. 2c). These findings were corroborated by reticulocyte fluorescence, a marker inversely correlated with maturity, demonstrating that P10 anemic mouse pups (n = 10 per each group) showed increased percentage (%) of high-fluorescence immature or young reticulocytes (51.80 ± 0.70 SD vs. control 46.0 ± 0.72 SD; p < 0.001) compared to low (older) (30.70 ± 0.44 SD vs. control 34.95 ± 0.77 SD; p < 0.001) and medium-fluorescence reticulocytes (maturing) (18.30 ± 0.24 SD vs. control 19.05 ± 0.23; p < 0.05) (Fig. 2d).

Fig. 2: Neonatal anemia in mice alters reticulocyte properties.
figure 2

Box whisker plots show the measurements of reticulocyte counts [%] (a) and reticulocyte hemoglobin [pg] (b) in C57BL/6 pups during each phlebotomy (P2, P4, P6, P8, and P10) with PIA-groups and non-phlebotomized control groups. Data represent 25 mice/each group; Šídák’s multiple comparisons test; ***P < 0.001 vs. respective age control. c Box whisker plot shows the concentrations of immature reticulocyte fraction [%] in P10 of control vs. PIA; data represent 10 mice/each group; Mann–Whitney U-test; **P < 0.01 vs. control. d Box whisker plots show the level of reticulocyte’s fluorescence [%] in P10 of control and PIA groups; (left) low-fluorescence, (middle) medium-fluorescence and (right) high-fluorescence; data represent 10 mice/each group; Mann–Whitney U-test; *P < 0.05, **P < 0.01, ***P < 0.001 vs. control.

RBC morphology in phlebotomy-induced anemia

We further investigate the RBC morphology in PIA pups by analyzing RBC indices. PIA exacerbated the normal reduction of anemic red cell indices, including MCV, MCH, and MCHC. PIA pups showed a significantly decreased MCV (fL) on P8 (68.07 ± 1.12 SD vs. control 76.89 ± 0.38 SD; p < 0.001; n = 25 per each group) (Fig. 3a), and MCH (pg) was found to be significantly reduced from P6 (22.16 ± 0.40 SD vs. 24.58 ± 0.41 control; p < 0.05) to P10 (14.67 ± 0.37 SD vs. 17.71 ± 0.41 control; p < 0.001; n = 25 per each group) (Fig. 3b). MCHC (g/dL) was slightly decreased from P6, then dropped down further at P10 (26.54 ± 0.41 SD vs. 29.40 ± 0.36 control; p < 0.001; n = 25 per each group) (Fig. 3c). The red cell distribution width (%) significantly increased at P8 (20.0 ± 0.31 SD vs. control 16.21 ± 0.28 SD; p < 0.001) and P10 (22.53 ± 0.45 vs. control 18.70 ± 0.33 SD; p < 0.001; n = 25 per each group) (Fig. 3d).

Fig. 3: RBC morphology in phlebotomy-induced anemia.
figure 3

Representative box whisker plots show the measurement of RBC indices including mean corpuscular volume [fL] a, mean corpuscular hemoglobin [pg] b, mean corpuscular hemoglobin concentration [g/dL] c, and red cell distribution width [%] d in serial time points of both the non-phlebotomized control and phlebotomized anemic groups. N = 25 mice per group. Šídák’s multiple comparisons test, *P < 0.05, ***P < 0.001.

WBC response in phlebotomy-induced anemia

Compared to their age-specific control mice, P4 and P6 anemic mouse pups (n = 20 per each group) showed relatively high WBC counts (×103/μL) (P4; 4.47 ± 0.17 vs. control 2.71 ± 0.06 SD; p < 0.001 and P6; 4.78 ± 0.18 vs. control 3.68 ± 0.16 SD; p < 0.001), which then dropped below P10 (3.58 ± 0.12 vs. control 4.95 ± 0.13 SD; p < 0.001; n = 20) (Fig. 4a). Monocytes (%) were the primary contributor to the increase in total WBC (P4; 26.55 ± 1.30 vs. control 20.40 ± 1.59 SD; p < 0.05 and P6; 31.91 ± 1.38 vs. control 24.30 ± 1.38 SD; p < 0.001; n = 20 per each group) (Fig. 4b) though neutrophils (%) also had a significant rise at P4 (26.20 ± 2.22 vs. control 19.45 ± 1.06 SD; p < 0.05; n = 20 per each group) (Fig. 4c). Both monocytes and neutrophils significantly dropped after P6. No significant lymphocyte (%) changes were noted between the two groups (n = 25 per each group) (Fig. 4d).

Fig. 4: WBC response in phlebotomy-induced anemia.
figure 4

Box whisker plots shows the count of WBC [×103/μL] (a), monocytes [%] (b), neutrophil [%] (c), and lymphocytes [%] (d) in C57BL/6 pups during each phlebotomy (P2, P4, P6, P8, and P10) with the PIA groups and non-phlebotomized control groups. Data represent 20 mice/each group; Šídák’s multiple comparisons test; *P < 0.05, **P < 0.01, ***P < 0.001 vs. respective age control.

Discussion

In this study, we present a detailed investigation of the hematological effects of PIA in pre-weaned mice. We observed that serial-timed phlebotomy in neonatal mice caused abnormalities in RBC content and their hemoglobin, reticulocyte properties, RBC morphology, and immune cell responses. These observations are similar to human findings, which have already established the ubiquitous nature of anemia in preterm infants and also provide additional evidence of anemia’s contribution to common co-morbidities. For example, we have previously described3 the increase in gut mucosal permeability resulting from PIA, due to hypoxia-mediated upregulation of microRNA let-7e-5p and evidenced by decreased levels of E-cadherin, an adherens junction protein.

Anemic pups with declining hematocrits expectedly showed a gradual reduction in RBC count during the period of study, reaching a reduction of 50% at P10. This is in contrast to control pups, in whom RBC count increased over the course of development (consistent with the findings of White et al.26). In anemic pups, hemoglobin counts initially dropped at P4 and then steadily maintained until P10. Reticulocytes are erythrocyte precursors whose count represents erythropoietic activity, a clue to distinguishing anemia caused by rapid destruction or loss from anemia caused by bone marrow suppression.27 Significantly higher reticulocyte counts were observed in our phlebotomy-induced anemic mouse pups after P5, indicating that phlebotomy does indeed stimulate bone marrow reticulocyte production. This finding mirrors the fact that corrected reticulocyte counts are higher in preterm human infants with blood loss and/or anemia of prematurity.28,29 However, the reticulocyte hemoglobin content is significantly reduced after P6, which is consistent with the loss of hemoglobin in PIA groups. Reticulocyte hemoglobin content is the strongest independent predictor of iron deficiency anemia, and though the level usually decreases after birth,30 phlebotomy exacerbates the rate of Ret-Hb decline. The higher reticulocyte count in anemic mouse pups represents brisk erythropoiesis, confirmed by a higher IRF in anemic pups. This was seen microscopically as the presence of increased “young immature reticulocytes” with high fluorescence.31 However, a significant reduction of reticulocyte low and medium fluorescence in PIA groups indicated a substantial loss of mature and/or old reticulocytes. This finding is additional evidence of a sudden erythropoietic response in response to blood loss.

Red cell morphology can assist in differentiating among various etiologies of anemia; as erythrocytes affected by blood loss, marrow failure, and hemolysis will likely appear differently under the microscope. MCV is a useful RBC parameter, characterizing anemia as microcytic, normocytic, or macrocytic, which may give clues to the underlying diagnosis.32 Anemic mouse pups showed significantly lowered MCV only on P8 compared to respective age controls, indicating that microcytic anemia develops after 3 timed phlebotomies and causes no changes at P10. However, the lower MCH on P8 and P10 in anemic mouse pups might be due to decreased hemoglobin at P6 onwards. In addition, the MCHC is slightly lower on P6 and P10, indicating that these anemic RBCs are hypochromic. Increased RDW in anemic mouse pups confirms the ineffective erythropoiesis in the bone marrow during phlebotomy, causing anisocytosis where RBCs are unequal in size. The RBC indices from PIA groups are similar to indices found in human infant populations.27

Our investigation of WBCs counts is based on the fact that some types of human anemia may affect the production of WBC precursors.33 In our PIA model, the WBC counts were relatively stable and slightly increased over the period of development in control mice groups; whereas anemic mouse pups showed a sudden increase of total WBC on P4 and continued slightly on P6, but dropped down at P10. The initial increase of WBC after the first phlebotomy might be a stress response to the sudden reduction in oxygen-carrying capacity and is unlikely to be attributed to infection. Since P4 is the day of the second blood draw, its results reflect any changes that took place between the first and second phlebotomies. Our previous findings25 confirmed that serial phlebotomy in mouse pups did not show an increased plasma endotoxin level until after P8 (i.e., measured at the time of the fourth phlebotomy), indicating that any rise in white count that occurs prior to P8 should be attributed to a separate phenomenon. Monocytes and neutrophils were slightly increased in response to phlebotomy and down trended close to control groups; these low counts in blood support our existing findings25 that circulating monocytes are likely recruited from blood to anemic organs, notably the hypoxic intestine. However, no changes occurred in lymphocytes, providing evidence that phlebotomy does not induce any T or B cell response.

In conclusion, this study has shown that phlebotomy-induced neonatal anemia can alter hematological parameters in mice. Our findings will lay the foundation for further preclinical investigation of the role that anemia plays in the development of neonatal co-morbidities.